Cannabis May Prevent and Treat Non-Alcohol Related Fatty Liver Disease

Cannabis may cannabisplanttreat as well as prevent non-alcohol related fatty liver disease, according to a study published this month in the Journal of Hepatology, and published online by the National Institute of Health.

According to researchers; “Obesity and associated metabolic syndrome have quickly become a pandemic and a major detriment to human health globally. The presence of non-alcoholic fatty liver disease (NAFLD; hepatosteatosis) in obesity has been linked to the worsening of the metabolic syndrome, including the development of insulin resistance and cardiovascular disease.”

Read moreCannabis May Prevent and Treat Non-Alcohol Related Fatty Liver Disease

Study: Cannabis May Treat Bacterial Translocation

Bacterial translocation, which is the migration of bacteria from the intestinal lumen to mesenteric lymph nodes (according to Medscape)cannabisisnotpot, is increased in those with cirrhosis, and can lead to spontaneous bacterial peritonitis (SBP). SBP is a condition which symptoms include fevers, chills and vomiting. According to a new study published by the Journal of Hepatology, cannabinoid receptor agonists – something which cannabis naturally is – may treat bacterial translocation and other “relevant abnormalities”.

For the study, researchers at the National Yang-Ming University School of Medicine, and Chang Gung University’s Graduate Institute of Traditional Chinese Medicine (both in Taiwan), gave cannabinoid receptor agonists to “thioacetamide (TAA)- and common bile duct ligation (BDL)-cirrhotic rats with ascites for 2-weeks and various measurement were performed.”

Read moreStudy: Cannabis May Treat Bacterial Translocation